Stoneridge Investment Partners LLC Invests $2.65 Million in Humana Inc. $HUM

Key Points

• Stoneridge Investment Partners LLC has acquired 10,013 shares of Humana Inc., valued at approximately $2,649,000, making it the firm's 12th largest position.
• Humana recently reported $6.27 EPS for the last quarter, missing estimates but achieving a revenue of $32.39 billion, which is an increase of 9.6% year-over-year.
• Several analysts have adjusted their price targets for Humana, with an average target priced at $281.43, reflecting mixed ratings with seven "Buy" and sixteen "Hold" recommendations.

Stoneridge Investment Partners LLC acquired a new stake in Humana Inc. (NYSE:HUM - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,013 shares of the insurance provider's stock, valued at approximately $2,649,000. Humana makes up 2.2% of Stoneridge Investment Partners LLC's investment portfolio, making the stock its 12th largest holding.

A number of other institutional investors have also recently made changes to their positions in the business. Cary Street Partners Investment Advisory LLC grew its holdings in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares in the last quarter. Applied Finance Capital Management LLC grew its holdings in Humana by 1.7% during the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after acquiring an additional 48 shares in the last quarter. Achmea Investment Management B.V. grew its holdings in Humana by 0.5% during the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after acquiring an additional 49 shares in the last quarter. Beech Hill Advisors Inc. grew its holdings in Humana by 6.1% during the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after acquiring an additional 50 shares in the last quarter. Finally, Townsquare Capital LLC grew its holdings in Humana by 2.8% during the 1st quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after acquiring an additional 61 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

HUM has been the subject of several analyst reports. Truist Financial lowered their price target on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a report on Wednesday, July 16th. Cantor Fitzgerald reiterated a "neutral" rating and set a $290.00 price target on shares of Humana in a report on Thursday, May 1st. Piper Sandler lowered their price target on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a report on Thursday, July 31st. Morgan Stanley reduced their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Finally, Bank of America reduced their price objective on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a research report on Tuesday, June 17th. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $283.29.

Humana Stock Up 1.9%

Shares of NYSE:HUM traded up $5.5420 during trading on Friday, hitting $300.0120. 1,615,505 shares of the company were exchanged, compared to its average volume of 1,879,934. The stock has a market capitalization of $36.08 billion, a P/E ratio of 23.02, a PEG ratio of 1.76 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $382.72. The firm's 50 day moving average price is $248.58 and its 200-day moving average price is $253.48.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter last year, the company earned $6.96 EPS. The firm's revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. On average, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana's dividend payout ratio is 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.